Could a single shot after surgery cut pain and opioid use?
NCT ID NCT07222748
Summary
This study is testing a new, long-acting pain medication called TLC590 for people having bunion surgery. Researchers want to see if a single injection of TLC590 at the surgery site works better and lasts longer than the current standard treatment or a placebo (saltwater shot). The main goal is to reduce pain in the first 3 days after surgery and see if patients need fewer opioid painkillers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology of Miami
NOT_YET_RECRUITINGMiami, Florida, 33172, United States
-
Endeavor Clinical Trials
NOT_YET_RECRUITINGSan Antonio, Texas, 78240, United States
-
First Surgical Hospital
RECRUITINGBellaire, Texas, 77401, United States
-
Memorial Hermann Village
RECRUITINGHouston, Texas, 77043, United States
Conditions
Explore the condition pages connected to this study.